Form 4: Natera Director James Healy Receives Stock Units in Lieu of Retainer Fees

Director James Healy received 153 fully vested Restricted Stock Units (RSUs) from Natera in lieu of quarterly retainer fees.

Summary

• James Healy, a director at Natera, Inc., received 153 shares of common stock on October 25, 2024.
• These shares were issued as Restricted Stock Units (RSUs) in place of $19,375 in quarterly retainer fees for his service on the Board of Directors.
• The RSUs were fully vested upon issuance.
• Healy directly owns 46,004 shares of Natera common stock after the transaction.
• He also indirectly owns 1,550,280 shares through Sofinnova Venture Partners IX, L.P., where he is a managing member of Sofinnova Management IX, L.L.C., the general partner.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally neutral to positive as it aligns director interests with shareholders. There are no indications of negative news or concerns.

Positives

• The issuance of RSUs to directors can align their interests with those of shareholders.
• The RSUs were fully vested at the time of issuance.

Industry Context

Director compensation through stock grants is a common practice in publicly traded companies, particularly in the biotech industry, to align the interests of board members with those of shareholders.

Comparison to Industry Standards

• Stock-based compensation for board members is a standard practice across the biotech industry.
• Companies like Illumina (ILMN) and Myriad Genetics (MYGN) also utilize stock options and restricted stock units as part of their director compensation packages.
• The amount of $19,375 per quarter in lieu of cash is within the typical range for board retainer fees in companies of Natera's size and stage.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders by aligning the director's interests with the company's long-term performance.

Key Dates